SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is currently trending due to securing an $816 million prime contract from the U.S. Space Force to develop and manufacture 18 missile defense satellites, with potential for total contract value up to $1 billion. The community is highly bullish, celebrating this as a transformative win that solidifies RKLB's role as a vertically integrated defense-space manufacturer. This major contract, alongside discussions of the broader space economy, is driving significant investor conversation and enthusiasm for the company's future.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines (LUNR) is trending with significant momentum following an analyst upgrade and heightened anticipation for the imminent NASA Lunar Terrain Vehicle (LTV) contract award. The community is actively debating recent insider share sales, which bulls largely view as routine pre-planned transactions amidst considerable short interest. This activity positions LUNR as a focal point within the accelerating space exploration sector.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending following its proposed merger with a nuclear fusion company, dramatically shifting its business focus into the speculative energy sector. This pivot is driving intense debate among investors, with supporters touting it as a visionary move for energy independence and significant future growth, while skeptics warn of substantial dilution and question the viability of merging a social media platform with a pre-revenue technology venture. The discussion is further amplified by broader political discourse, contributing to high volatility and strong polarization in community sentiment surrounding the stock.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network ($ZBCN) is trending as the community eagerly anticipates confirmed ISO 20022 compliance and the launch of its Super App, alongside recent strategic partnerships with entities like NatPay, Fasset, and Dash. Discussions highlight Zebec's foundational work in real-time compliant payments, leading many to accumulate and stake tokens. This robust development in payment infrastructure and global utility is driving comparison to established compliant digital assets, with community members expressing strong conviction for significant long-term growth despite observed market fluctuations.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is trending as political discourse intensifies around healthcare costs, with public statements calling for insurance companies to reduce prices. The community is actively debating the potential for a market impact, with some anticipating declines for the sector while others view the rhetoric as political maneuvering that could still lead to long-term benefits for diversified players like UNH. Additional discussions include the potential implications of ongoing talks about ACA subsidies and the company's recently adopted operational improvements following independent audits.

Newegg Commerce, Inc. is an e-commerce company. It offers direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products. The firm also provides third-party logistics services globally. The company was founded on July 22, 2003 and is headquartered in City of Industry, CA.

Newegg Commerce Inc

Newegg is trending amidst significant insider buying from Vladimir Galkin, who is rapidly consolidating ownership, and recent business developments like its PayPal AI integration and SHEIN marketplace launch. The community is intensely focused on the stock's extremely low free float and allegations of market manipulation, spurring widespread talk of an impending short squeeze. Many investors remain committed, viewing current price movements as attempts by short sellers to control the narrative before a substantial upward move.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave (CRWV) is trending with strong market activity after being selected for the Department of Energy's Genesis Mission, a move interpreted as significant government validation for its AI infrastructure. This news, bolstered by renewed analyst coverage, is driving a surge in positive sentiment and has triggered extensive short covering. While many investors are celebrating substantial gains and the strategic importance of this development, a segment of the community remains concerned about insider selling and long-term financial metrics.

Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility. Its clinical-stage drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator, CK-136, a novel cardiac troponin activator, reldesemtiv, a novel fast skeletal muscle troponin activator, aficamten, a novel cardiac myosin inhibitor, and CK-3772271, a novel cardiac myosin inhibitor. The company was founded by Ronald D. Vale, Lawrence S. B. Goldstein, James H. Sabry, and James A. Spudich in 1997 and is headquartered in South San Francisco, CA.

Cytokinetics Inc

Cytokinetics is trending following the FDA approval of MYQORZO (aficamten) for symptomatic obstructive hypertrophic cardiomyopathy, a groundbreaking treatment that has ignited significant community discussion. Investors are highlighting its favorable REMS program and differentiated profile compared to existing therapies, positioning it as a potential new standard of care in the sector. This pivotal regulatory milestone continues to fuel ongoing speculation regarding potential future acquisition interest in the company.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is trending due to its recent selection by the US Department of Commerce to publish official macroeconomic data on-chain, solidifying its position as a critical oracle provider. The community is actively discussing PYTH's potential as a 'government-vetted' project within the Real World Asset (RWA) narrative, often comparing its long-term prospects favorably against other oracle solutions.

NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase and DERMAdoctor. The company was founded on January 19, 2000 and is headquartered in Emeryville, CA.

Novabay Pharmaceuticals Inc

Novabay Pharmaceuticals is trending with intense trading activity, driven by a recent analyst "buy" rating and an upcoming special cash dividend. Community discussion is focused on the company's hinted pivot towards blockchain-based assets and its historically high short interest, contributing to significant volatility and mixed sentiment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AngioDynamics (NASDAQ:ANGO) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen raised AngioDynamics from a "hold" rating to a "buy" rating in a report on Saturday...

Armistice Capital LLC Sells 566,185 Shares of AngioDynamics, Inc. $ANGO

Armistice Capital LLC decreased its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 27.0% during the second quarter, according to its most recent filing with the SEC. The...

AngioDynamics, Inc. $ANGO Shares Purchased by Divisadero Street Capital Management LP

Divisadero Street Capital Management LP lifted its position in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 253.7% in the second quarter, according to its most recent filing with the...

77,141 Shares in AngioDynamics, Inc. $ANGO Acquired by Stonepine Capital Management LLC

Stonepine Capital Management LLC bought a new stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with...

Panagora Asset Management Inc. Sells 138,518 Shares of AngioDynamics, Inc. $ANGO

Panagora Asset Management Inc. reduced its stake in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 47.1% during the second quarter, according to the company in its most recent filing with the...

AngioDynamics (NASDAQ:ANGO) Hits New 1-Year High - What's Next?

AngioDynamics (NASDAQ:ANGO) Reaches New 12-Month High - Should You Buy...

Wall Street Zen raised AngioDynamics from a "hold" rating to a "buy" rating in a research note on Friday...

Segall Bryant & Hamill LLC Has $13.46 Million Position in AngioDynamics, Inc. $ANGO

Segall Bryant & Hamill LLC cut its stake in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 2.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange...

Envestnet Asset Management Inc. Sells 172,625 Shares of AngioDynamics, Inc. $ANGO

Envestnet Asset Management Inc. cut its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 71.7% during the 2nd quarter, according to its most recent 13F filing with the Securities...

Integrated Quantitative Investments LLC Buys New Position in AngioDynamics, Inc. $ANGO

Integrated Quantitative Investments LLC bought a new position in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) during the second quarter, according to its most recent disclosure with the...

AngioDynamics, Inc. is a medical device company, which engages in the development, manufacturing, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. The firm offers ablation systems, fluid management systems, vascular access, angiographic, drainage, thrombolytic, and venous products. It operates through the Med Tech and Med Device segments. The Med Tech segment consists of technology portfolio including Auryon, the thrombus management platform and NanoKnife. The Med Device segment focuses on core, venous, ports, and other oncology products. The company was founded by Howard S. Stern and Eamonn P. Hobbs on February 9, 1988 and is headquartered in Latham, NY.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '25	-$0.10	--	--	N/A
Q1 '25	-$0.12	-$0.10	18.32%	BEAT
Q4 '24	-$0.12	-$0.03	74.72%	BEAT
Q3 '24	-$0.13	-$0.08	38.46%	BEAT
Q2 '24	-$0.11	-$0.04	63.64%	BEAT

ANGO
Angiodynamic Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q2 '25

Historical Earnings

Latest ANGO News

ANGOAngiodynamic Inc